Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 22, 2021 at 04:08 am EDT
Share
Autobio Diagnostics Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 817.001 million compared to CNY 550.376 million a year ago. Operating income was CNY 192.502 million compared to CNY 112.090 million a year ago. Net income was CNY 171.482 million compared to CNY 93.119 million a year ago. Basic earnings per share from continuing operations was CNY 0.38 compared to CNY 0.22 a year ago.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
AUTOBIO DIAGNOSTICS CO., LTD. 
